Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Redirected Auto T Cells for Advanced Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Adaptimmune
University of Maryland Greenebaum Cancer Center
Abramson Cancer Center of the University of Pennsylvania
Information provided by (Responsible Party):
Adaptimmune Identifier:
First received: May 4, 2011
Last updated: October 30, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2031
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)